TY  - GEN
AU  - Santos,Edgardo S
TI  - Treatment options after first-line immunotherapy in metastatic NSCLC
SN  - 1744-8328
PY  - 2021///0128
KW  - Carcinoma, Non-Small-Cell Lung
KW  - immunology
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - administration & dosage
KW  - Immunotherapy
KW  - adverse effects
KW  - Lung Neoplasms
KW  - Quality of Life
KW  - Survival Rate
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1080/14737140.2020.1738930
ER  -